Incidence of Impaired Glucose Tolerance Assessed by Glycated Hemoglobin and Fasting Plasma Glucose in Patients with Acute Coronary Syndromes and its Impact on Clinical and Angiographic Outcomes

  • Marian Mamdouh Abdelnor Assiut University Hospital
  • Yehia Kishk
  • Hatem Helmy
  • Mohamed aboelkassem

Abstract

Impaired glucose tolerance (IGT); diabetes and prediabetes, is common among patients with CAD. Diabetic patients usually have a worse clinical course, so it is important to detect diabetes and even prediabetes, since progress to T2DM can be retarded by lifestyle interventions. It is known that OGTT is recommended in patients with CAD, but still HbA1c and FPG are more clinically applicable. Our study aimed to assess the incidence of IGR in patients with ACS using HbA1 and FPG as most of previous studies used OGTT and to study the impact of IGR on in hospital clinical outcomes and severity of coronary arteries lesions using Syntax score.

Published
Oct 7, 2017
How to Cite
ABDELNOR, Marian Mamdouh et al. Incidence of Impaired Glucose Tolerance Assessed by Glycated Hemoglobin and Fasting Plasma Glucose in Patients with Acute Coronary Syndromes and its Impact on Clinical and Angiographic Outcomes. International Annals of Medicine, [S.l.], v. 1, n. 10, oct. 2017. ISSN 2520-5110. Available at: <https://iamresearcher.online/ojs/index.php/iam/article/view/324>. Date accessed: 11 dec. 2017. doi: https://doi.org/10.24087/IAM.2017.1.10.324.
Section
Original Research